You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • AB0284 Long term safety of iv golimumab and comparisons with sc golimumab in rheumatologic conditions: results from the 120-day safety report of go-further trial

Article metrics

Article menu
Download PDFPDF
Abstracts accepted for publication
Rheumatoid arthritis - anti-TNF therapy
AB0284 Long term safety of iv golimumab and comparisons with sc golimumab in rheumatologic conditions: results from the 120-day safety report of go-further trial

 

Online download statistics by month:

Online download statistics by month: February 2014 to December 2023

AbstractFullPdf
Feb 20142703
Mar 2014300
Apr 2014801
May 20141100
Jun 20141100
Jul 20141000
Aug 2014300
Sep 2014901
Oct 2014702
Nov 20141001
Dec 2014400
Jan 20151602
Feb 2015600
Mar 2015601
Apr 20151300
May 2015600
Jun 2015200
Jul 2015700
Aug 2015300
Sep 20151000
Nov 2015300
Dec 2015400
Jan 2016601
Feb 2016100
Apr 20161300
May 2016701
Jun 2016300
Jul 2016700
Aug 2016300
Sep 2016300
Oct 2016300
Nov 2016800
Dec 20161000
Jan 2017400
Feb 2017400
Mar 2017800
Apr 2017300
May 20171000
Jun 2017500
Jul 2017800
Aug 20171001
Sep 20171000
Oct 2017400
Nov 2017400
Dec 2017600
Jan 20181601
Feb 2018400
Mar 20181400
Apr 20181400
May 20181601
Jun 20181400
Jul 2018800
Aug 2018600
Sep 2018600
Oct 2018200
Nov 2018400
Dec 2018400
Jan 2019400
Feb 2019200
Apr 2019600
Jun 2019200
Aug 20191202
Dec 2019300
Apr 2020200
Jul 2020200
Sep 20201000
Nov 2020500
Dec 2020200
Jan 2021200
Apr 2021400
May 2021401
Aug 2021001
Nov 20211400
Dec 2021600
Jan 2022200
Feb 2022400
Mar 2022400
May 2022800
Jul 20221200
Aug 2022600
Sep 2022200
Oct 2022200
Nov 2022400
Dec 2022400
Jan 2023400
Mar 2023700
May 20231200
Jul 2023200
Aug 2023200
Sep 2023600
Oct 2023200
Nov 2023100
Dec 2023600
Total597020